Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind multicenter study of GBI268 injection for post-hemorrhoidectomy analgesia or intraoperative local anesthesia
CTR20252525Phase 2Completed
- Sponsor
- Guangzhou Zhiyao Biotechnology
- Start
- Aug 2025
- Modality
- Small Molecules, Liposomes → Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of GBI268 in postoperative pain, sponsored by Guangzhou Zhiyao Biotechnology. Started Aug 2025; status: completed.
02
Drugs
GBI268
03
Conditions
postoperative pain
Beyond the preview
Go deeper on CTR20252525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20252525.